These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23931623)

  • 21. Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry.
    Mulcahy SP; Gründler K; Frias C; Wagner L; Prokop A; Meggers E
    Dalton Trans; 2010 Sep; 39(35):8177-82. PubMed ID: 20689887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalysis with complexes containing stereogenic metal centers.
    Kündig EP
    Chimia (Aarau); 2014; 68(5):312-4. PubMed ID: 24983806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionalization of glucose at position C-3 for transition metal coordination: organo-rhenium complexes with carbohydrate skeletons.
    Dumas C; Petrig J; Frei L; Spingler B; Schibli R
    Bioconjug Chem; 2005; 16(2):421-8. PubMed ID: 15769097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium(II) metallo-intercalators: DNA imaging and cytotoxicity.
    Gill MR; Derrat H; Smythe CG; Battaglia G; Thomas JA
    Chembiochem; 2011 Apr; 12(6):877-80. PubMed ID: 21433240
    [No Abstract]   [Full Text] [Related]  

  • 25. Porphyrin complexes of the period 6 main group and late transition metals.
    Lemon CM; Brothers PJ; Boitrel B
    Dalton Trans; 2011 Jul; 40(25):6591-609. PubMed ID: 21384031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and crystal structure of some transition metal complexes with a novel bis-Schiff base ligand and their antitumor activities.
    Zhong X; Yi J; Sun J; Wei HL; Liu WS; Yu KB
    Eur J Med Chem; 2006 Sep; 41(9):1090-2. PubMed ID: 16782235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond catalysis: N-heterocyclic carbene complexes as components for medicinal, luminescent, and functional materials applications.
    Mercs L; Albrecht M
    Chem Soc Rev; 2010 Jun; 39(6):1903-12. PubMed ID: 20502793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of d6 transition metal complexes in fluorescence cell imaging.
    Fernández-Moreira V; Thorp-Greenwood FL; Coogan MP
    Chem Commun (Camb); 2010 Jan; 46(2):186-202. PubMed ID: 20024327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organometallic ruthenium and osmium compounds of pyridin-2- and -4-ones as potential anticancer agents.
    Henke H; Kandioller W; Hanif M; Keppler BK; Hartinger CG
    Chem Biodivers; 2012 Sep; 9(9):1718-27. PubMed ID: 22976964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates.
    Zhao T; Grützke M; Götz KH; Druzhenko T; Huhn T
    Dalton Trans; 2015 Oct; 44(37):16475-85. PubMed ID: 26325575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
    Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imidazolium ionic liquids as promoters and stabilising agents for the preparation of metal(0) nanoparticles by reduction and decomposition of organometallic complexes.
    Prechtl MH; Campbell PS; Scholten JD; Fraser GB; Machado G; Santini CC; Dupont J; Chauvin Y
    Nanoscale; 2010 Dec; 2(12):2601-6. PubMed ID: 20936213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and characterization of the ligand based on benzoxazole and its transition metal complexes: DNA-binding and antitumor activity.
    Jiang J; Tang X; Dou W; Zhang H; Liu W; Wang C; Zheng J
    J Inorg Biochem; 2010 May; 104(5):583-91. PubMed ID: 20202687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyanionic N-donor ligands as chelating agents in transition metal complexes: synthesis, structural characterization and antiviral properties against HIV.
    García-Gallego S; Rodríguez JS; Jiménez JL; Cangiotti M; Ottaviani MF; Muñoz-Fernández MÁ; Gómez R; de la Mata FJ
    Dalton Trans; 2012 Jun; 41(21):6488-99. PubMed ID: 22314266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Heterocyclic carbene metal complexes in medicinal chemistry.
    Oehninger L; Rubbiani R; Ott I
    Dalton Trans; 2013 Mar; 42(10):3269-84. PubMed ID: 23223752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
    Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A gold(III) porphyrin complex as an anti-cancer candidate to inhibit growth of cancer-stem cells.
    Lum CT; Wong AS; Lin MC; Che CM; Sun RW
    Chem Commun (Camb); 2013 May; 49(39):4364-6. PubMed ID: 23223325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visible light photoredox catalysis with transition metal complexes: applications in organic synthesis.
    Prier CK; Rankic DA; MacMillan DW
    Chem Rev; 2013 Jul; 113(7):5322-63. PubMed ID: 23509883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.